Glenmark Pharma eyes up to 15% consolidated revenue growth over 3 to 5 years

Glenmark is targeting a consolidated revenue growth of 12-15 percent over the next 3-5 years, while focusing on margin expansion, the company said.

from Moneycontrol Business News
Read The Rest:moneycontrol...